Dr. Jay Traverse, MD
Claim this profileMinneapolis Heart Institute Foundation
Studies Coronary Artery Disease
Studies Myocardial Ischemia
7 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Jay Traverse, MD is currently running
NAN-101
for Heart Failure
This trial tests a new heart treatment given directly into the heart's blood vessels. It aims to help patients with severe heart failure who have significant symptoms and limited physical activity. The treatment is designed to improve heart function and quality of life.
Recruiting1 award Phase 18 criteria
AB-1002
for Heart Failure
This is a Phase 2 adaptive, double-blinded, placebo-controlled, randomized, multi-center trial study to evaluate the safety and efficacy of a single dose of AB-1002, administered via antegrade intracoronary artery infusion, in males and females age \>18 years with non-ischemic cardiomyopathy and NYHA Class III symptoms of HF. Subjects will be randomized into one of three treatment groups in a 1:1:1
Recruiting0 awards Phase 28 criteria
More about Jay Traverse, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jay Traverse, MD has experience with
- NAN-101
- Firehawk Stent
- 2nd Generation DES (XIENCE Family, Promus Family, Resolute/Onyx Family/Endeavor, And Orsiro Stent)
- AdVEGFXC1
- CLBS16
- Placebo
Breakdown of trials Jay Traverse, MD has run
Coronary Artery Disease
Myocardial Ischemia
Heart Disease
Coronary Heart Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jay Traverse, MD specialize in?
Jay Traverse, MD focuses on Coronary Artery Disease and Myocardial Ischemia. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Jay Traverse, MD currently recruiting for clinical trials?
Yes, Jay Traverse, MD is currently recruiting for 2 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Jay Traverse, MD has studied deeply?
Yes, Jay Traverse, MD has studied treatments such as NAN-101, Firehawk Stent, 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent).
What is the best way to schedule an appointment with Jay Traverse, MD?
Apply for one of the trials that Jay Traverse, MD is conducting.
What is the office address of Jay Traverse, MD?
The office of Jay Traverse, MD is located at: Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407 United States. This is the address for their practice at the Minneapolis Heart Institute Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.